PROGNOSTIC VALUE OF ELEVATED LIPOPROTEIN (A) CONCENTRATION TO PREDICT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS

被引：0
|
作者：
Shishikura, Daisuke [1 ]
Harada-Shiba, Mariko [1 ]
Fujisaka, Tomohiro [1 ]
Morita, Hideaki [1 ]
Kanzaki, Yumiko [1 ]
Hoshiga, Masaaki [1 ]
机构：
[1] Osaka Med & Pharmaceut Univ, Cardiol, Takatsuki, Osaka, Japan
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SaaG054
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH
    Panagiotis Anagnostis
    Christos V. Rizos
    Ioannis Skoumas
    Loukianos Rallidis
    Konstantinos Tziomalos
    Emmanuel Skalidis
    Vasileios Kotsis
    Michalis Doumas
    Genovefa Kolovou
    George Sfikas
    Anastasia Garoufi
    Vaia Lambadiari
    Ioanna Dima
    Estela Kiouri
    Dimitrios Agapakis
    Evangelos Zacharis
    Christina Antza
    Vana Kolovou
    Charalambos Koumaras
    George Bantouvakis
    George Liamis
    Evangelos N. Liberopoulos
    Endocrine, 2022, 76 : 324 - 330
  • [42] Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients
    Perez-Calahorra, Sofia
    Maria Sanchez-Hernandez, Rosa
    Plana, Nuria
    Marco-Benedi, Victoria
    Pedro-Botet, Juan
    Almagro, Fatima
    Brea, Angel
    Francisco Ascaso, Juan
    Lahoz, Carlos
    Civeira, Fernando
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (05): : 742 - 748
  • [43] ASSOCIATION BETWEEN LIPOPROTEIN(A) CONCENTRATIONS AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: AN ANALYSIS FROM THE HELLAS-FH
    Anagnostis, P. G.
    Rizos, C.
    Skoumas, I.
    Rallidis, L.
    Tziomalos, K.
    Skalidis, E.
    Kotsis, V.
    Doumas, M.
    Kolovou, G.
    Sfikas, G.
    Garoufi, A.
    Lambadiari, V.
    Dima, I.
    Kiouri, E.
    Agapakis, D.
    Zacharis, E.
    Antza, C.
    Kolovou, V.
    Koumaras, C.
    Bantouvakis, G.
    Liamis, G.
    Liberopoulos, E.
    ATHEROSCLEROSIS, 2022, 355 : E55 - E57
  • [44] Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease
    Mallya, Usha G.
    Boklage, Susan H.
    Koren, Andrew
    Delea, Thomas E.
    Mullins, C. Daniel
    PHARMACOECONOMICS, 2018, 36 (01) : 115 - 126
  • [45] Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease
    Usha G. Mallya
    Susan H. Boklage
    Andrew Koren
    Thomas E. Delea
    C. Daniel Mullins
    PharmacoEconomics, 2018, 36 : 115 - 126
  • [46] Vascular Age in Patients With Familial Hypercholesterolemia and/or Elevated Lipoprotein(a) Treated With Lipoprotein Apheresis
    Safarova, Maya S.
    Gorby, Lauryn
    Nugent, Anne
    Dutton, Julie-Ann
    Moriarty, Patrick M.
    CIRCULATION, 2021, 144
  • [47] Association between Achilles Tendon Softness and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia
    Michikura, Masahito
    Ogura, Masatsune
    Hori, Mika
    Matsuki, Kota
    Makino, Hisashi
    Hosoda, Kiminori
    Harada-Shiba, Mariko
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (11) : 1603 - 1612
  • [48] Choice of initial treatment with cholesterol lowering drugs in patients with familial hypercholesterolemia, atherosclerotic cardiovascular disease, or increased risk of atherosclerotic cardiovascular disease
    Hoe, Jakob Kronkvist
    Jensen, Camilla B.
    Hansen, Susanne
    Olsen, Rasmus Huan
    Johansen, Tina
    Jimenez-Solem, Espen
    Petersen, Janne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 178 - 179
  • [49] Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia
    Ogura, Masatsune
    Hori, Mika
    Harada-Shiba, Mariko
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (01) : 181 - 188
  • [50] Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia
    Antonio Gallo
    Reed Mszar
    Marcio Hiroshi Miname
    Current Atherosclerosis Reports, 2022, 24 : 407 - 418
12345